Plasma D-dimer and peritoneal CA-125 lev
β
Peter G. Rose; Jill M. Terrien; Stephen Baker
π
Article
π
1994
π
John Wiley and Sons
π
English
β 429 KB
## Abstract Although serum CAβ125 has improved our ability to monitor tumor response in ovarian carcinoma, βΌ50% of patients with normalization of CAβ125 have persistent disease at second look laparotomy. Peritoneal CAβ125 and plasma DβDimer levels were studied to determine if their use could increa